Annual Current Assets
$67.25 M
-$41.34 M-38.07%
December 31, 2023
Summary
- As of February 8, 2025, SNSE annual total current assets is $67.25 million, with the most recent change of -$41.34 million (-38.07%) on December 31, 2023.
- During the last 3 years, SNSE annual current assets has risen by +$47.17 million (+234.98%).
- SNSE annual current assets is now -54.73% below its all-time high of $148.54 million, reached on December 31, 2021.
Performance
SNSE Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$48.10 M
-$5.85 M-10.84%
September 30, 2024
Summary
- As of February 8, 2025, SNSE quarterly total current assets is $48.10 million, with the most recent change of -$5.85 million (-10.84%) on September 30, 2024.
- Over the past year, SNSE quarterly current assets has dropped by -$19.15 million (-28.48%).
- SNSE quarterly current assets is now -72.16% below its all-time high of $172.78 million, reached on March 31, 2021.
Performance
SNSE Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
SNSE Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.1% | -28.5% |
| 3 y3 years | +235.0% | -55.7% |
| 5 y5 years | +5153.9% | -55.7% |
SNSE Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.7% | at low | -67.6% | at low |
| 5 y | 5-year | -54.7% | >+9999.0% | -72.2% | +9481.3% |
| alltime | all time | -54.7% | >+9999.0% | -72.2% | +9481.3% |
Sensei Biotherapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $48.10 M(-10.8%) |
| Jun 2024 | - | $53.94 M(-10.4%) |
| Mar 2024 | - | $60.23 M(-10.4%) |
| Dec 2023 | $7.12 M(-27.2%) | $67.25 M(-8.9%) |
| Sep 2023 | - | $73.84 M(-8.9%) |
| Jun 2023 | - | $81.07 M(-17.8%) |
| Mar 2023 | - | $98.61 M(-9.2%) |
| Dec 2022 | $9.79 M | $108.59 M(-8.3%) |
| Sep 2022 | - | $118.48 M(-7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $127.49 M(-8.3%) |
| Mar 2022 | - | $138.98 M(-6.4%) |
| Dec 2021 | $4.68 M(+246.4%) | $148.54 M(-6.1%) |
| Sep 2021 | - | $158.16 M(-4.5%) |
| Jun 2021 | - | $165.61 M(-4.2%) |
| Mar 2021 | - | $172.78 M(+760.7%) |
| Dec 2020 | $1.35 M(+89.1%) | $20.08 M(+353.3%) |
| Sep 2020 | - | $4.43 M(+782.3%) |
| Dec 2019 | $715.00 K(+25.4%) | $502.00 K |
| Dec 2018 | $570.00 K | - |
FAQ
- What is Sensei Biotherapeutics annual total current assets?
- What is the all time high annual current assets for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics annual current assets year-on-year change?
- What is Sensei Biotherapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics quarterly current assets year-on-year change?
What is Sensei Biotherapeutics annual total current assets?
The current annual current assets of SNSE is $67.25 M
What is the all time high annual current assets for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high annual total current assets is $148.54 M
What is Sensei Biotherapeutics annual current assets year-on-year change?
Over the past year, SNSE annual total current assets has changed by -$41.34 M (-38.07%)
What is Sensei Biotherapeutics quarterly total current assets?
The current quarterly current assets of SNSE is $48.10 M
What is the all time high quarterly current assets for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high quarterly total current assets is $172.78 M
What is Sensei Biotherapeutics quarterly current assets year-on-year change?
Over the past year, SNSE quarterly total current assets has changed by -$19.15 M (-28.48%)